RESEARCHER PROFILE
Robert Babela
← Back to Slovak Medical University
R
Slovak Medical University
Robert Babela works in Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, Pharmaceutical Economics and Policy, Antibiotic Resistance in Bacteria, Multiple Myeloma Research and Treatments. Recorded institutional associations include Slovak Medical University.
65Publications
790Citations
8H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group
2015 · 590 citationsNosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors
2001 · 42 citationsProspective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults
2000 · 36 citationsThe effect of passive smoking on bacterial colonisation of the upper airways and selected laboratory parameters in children
2018 · 20 citationsCost-effectiveness of colorectal cancer screening in Slovakia
2021 · 16 citationsCandidemia in the Surgical Intensive Care Unit
2002 · 13 citationsAntibiotic Use and Development of Resistance in Blood Culture Isolates: 8 Years of Experience from a Cancer Referral Center
2001 · 8 citationsEtiology, Risk Factors and Outcome of 1003 Cases of Infective Endocarditis from a 33-year National Survey in the Slovak Republic: An increasing proportion of elderly patients.
2019 · 8 citationsACINETOBACTER BAUMANII BACTEREMIA IN CHILDREN
2001 · 7 citationsNosocomial Enterococcal Bacteremia in Children
2003 · 6 citationsMortality Associated with Breakthrough Candidemia among Patients with and Those without Cancer
2002 · 5 citationsEconomic aspects of multiple myeloma: real costs associated with disease in the Slovak Republic
2021 · 5 citationsEconomic burden of multiple sclerosis in Slovakia — from 2015 to 2020
2022 · 4 citationsProstate cancer in Slovakia: last decade overview
2024 · 4 citationsCost-effectiveness of the SQ HDM SLIT-tablet for the treatment of allergic asthma in three Eastern European Countries
2018 · 3 citationsDecision and cost analysis of empirical antibiotic therapy of acute sinusitis in the era of increasing antimicrobial resistance: do we have an additional tool for antibiotic policy decisions?
2017 · 3 citationsEpidemiology and comprehensive economic impact of atrial fibrillation and associated stroke in Slovakia
2024 · 3 citationsAcinetobacter baumanii (AB) bacteremia in cancer patients
2001 · 2 citationsWhat are the Real Indirect Costs Associated with Multiple Myeloma: Model Patient Analysis From Slovak Republic
2018 · 2 citations[Management of acute anaphylaxis in clinical practice in the context of the guidelines].
2019 · 2 citationsAcinetobacter baumanii (AB) Bacteraemia in Surgical Patients (Letter)
2001 · 1 citationsSocial Marketing as a Tool to Improve Behavioral Health Services for Underserved Populations in Transition Countries
2005 · 1 citationsResistance to Penicillin and Erythromycin in Viridans Streptococcal Bloodstream Isolates From Cancer and Non-Cancer Patients Within 10 Years
2004 · 1 citationsDirect Costs Associated with Multiple Myeloma Model Patient in 2017 From Single EU Jurisdiction
2018 · 1 citationsTotal Costs Distribution for Multiple Myeloma in Single Upper Middle Income Country: Is Cost Data Distribution Comparable with High Income Countries?
2018 · 1 citations
